Role of Cardiac MRI in the Assessment of Cardiomyopathy

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Current Treatment Options in Cardiovascular Medicine

• Publication date

  2015-10-08

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11936-015-0410-1PMID 26446716
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rest perfusion abnormalities in hypertrophic cardiomyopathy: correlation with myocardial fibrosis and risk factors for sudden cardiac death

  2015cited by this paper
• Cardiac Sarcoidosis

  2015cited by this paper
• Late gadolinium enhancement identified with cardiac magnetic resonance imaging in sarcoidosis patients is associated with long-term ventricular arrhythmia and sudden cardiac death.

  2015cited by this paper
• Cardiac magnetic resonance in clinical cardiology.

  2015cited by this paper
• Prevalence of Myocardial Fibrosis Patterns in Patients With Systolic Dysfunction: Prognostic Significance for the Prediction of Sudden Cardiac Arrest or Appropriate Implantable Cardiac Defibrillator Therapy

  2014cited by this paper
• Impact of the presence and amount of myocardial fibrosis by cardiac magnetic resonance on arrhythmic outcome and sudden cardiac death in nonischemic dilated cardiomyopathy.

  2014cited by this paper
• Distribution of late gadolinium enhancement in various types of cardiomyopathies: Significance in differential diagnosis, clinical features and prognosis.

  2014cited by this paper
• Biventricular myocardial strain analysis in patients with arrhythmogenic right ventricular cardiomyopathy (ARVC) using cardiovascular magnetic resonance feature tracking

  2014cited by this paper
• Infarct Tissue Heterogeneity by Contrast-Enhanced Magnetic Resonance Imaging Is a Novel Predictor of Mortality in Patients With Chronic Coronary Artery Disease and Left Ventricular Dysfunction

  2014cited by this paper
• Distribution of late gadolinium enhancement in end-stage hypertrophic cardiomyopathy and dilated cardiomyopathy: differential diagnosis and prediction of cardiac outcome.

  2014cited by this paper
• Cardiac Sarcoidosis: Clinical Manifestations, Imaging Characteristics, and Therapeutic Approach

  2014cited by this paper
• Myocardial Tissue Characterization: Histological and Pathophysiological Correlation

  2014cited by this paper
• Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance for the Evaluation of Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy

  2014cited by this paper
• Prognostic significance of LGE by CMR in aortic stenosis patients undergoing valve replacement.

  2014cited by this paper
• CMR and amyloid cardiomyopathy: are we getting closer to the biology?

  2014cited by this paper
• T1 mapping and survival in systemic light-chain amyloidosis

  2014cited by this paper
• T1 Measurements Identify Extracellular Volume Expansion in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers With and Without Left Ventricular Hypertrophy

  2013cited by this paper
• Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement

  2013cited by this paper
• Cardiac magnetic resonance imaging of systemic amyloidosis patients with normal left ventricular ejection fraction: An initial study

  2013cited by this paper
• Arrhythmogenic right ventricular cardiomyopathy mimics: role of cardiovascular magnetic resonance

  2013cited by this paper
• Hypertrophic cardiomyopathy

  2013cited by this paper
• Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis.

  2013cited by this paper
• Identification and Assessment of Anderson-Fabry Disease by Cardiovascular Magnetic Resonance Noncontrast Myocardial T1 Mapping

  2013cited by this paper
• Markedly increased volume of distribution of gadolinium in cardiac amyloidosis demonstrated by T1 mapping

  2013cited by this paper
• Standardized cardiovascular magnetic resonance (CMR) protocols 2013 update

  2013cited by this paper
• CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis.

  2013cited by this paper
• Quantification of Myocardial Extracellular Volume Fraction in Systemic AL Amyloidosis: An Equilibrium Contrast Cardiovascular Magnetic Resonance Study

  2013cited by this paper
• INFARCT TISSUE HETEROGENEITY BY CONTRAST-ENHANCED MRI IS A NOVEL PREDICTOR OF MORTALITY IN PATIENTS WITH CHRONIC CORONARY ARTERY DISEASE AND LEFT VENTRICULAR DYSFUNCTION

  2013cited by this paper
• Extracellular volume fraction mapping in the myocardium, part 2: initial clinical experience

  2012cited by this paper
• CMR imaging assessing viability in patients with chronic ventricular dysfunction due to coronary artery disease: a meta-analysis of prospective trials.

  2012cited by this paper
• Cardiac Sarcoid: A Clinician's Review on How to Approach the Patient With Cardiac Sarcoid

  2012cited by this paper
• Prevalence of scarred and dysfunctional myocardium in patients with heart failure of ischaemic origin: A cardiovascular magnetic resonance study

  2011cited by this paper
• ARVC: Imaging diagnosis is still in the eye of the beholder.

  2011cited by this paper
• Cardiac sarcoidosis: a comprehensive review

  2011cited by this paper
• Cardiac magnetic resonance assessment of myocardial fibrosis: honing new clinical tools.

  2011cited by this paper
• Arrhythmogenic right ventricular cardiomyopathy/dysplasia: a review and update

  2011cited by this paper
• Characteristics and Clinical Significance of Late Gadolinium Enhancement by Contrast-Enhanced Magnetic Resonance Imaging in Patients With Hypertrophic Cardiomyopathy

  2010cited by this paper
• Equilibrium Contrast Cardiovascular Magnetic Resonance for the Measurement of Diffuse Myocardial Fibrosis: Preliminary Validation in Humans

  2010cited by this paper
• Comparison of global and regional abnormalities in 99mTc-sestamibi and cardiac magnetic resonance imaging in dilated cardiomyopathy.

  2010cited by this paper
• Assessment of cardiac masses: magnetic resonance imaging versus transthoracic echocardiography.

  2010cited by this paper
• Prediction of global left ventricular functional recovery in patients with heart failure undergoing surgical revascularisation, based on late gadolinium enhancement Cardiovascular Magnetic Resonance

  2010cited by this paper
• Replacement and reactive myocardial fibrosis in idiopathic dilated cardiomyopathy: comparison of magnetic resonance imaging with right ventricular biopsy

  2010cited by this paper
• Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Proposed Modification of the Task Force Criteria

  2010cited by this paper
• Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper

  2009cited by this paper
• Journal of Cardiovascular Magnetic Resonance Open Access Myocardial Tissue Tagging with Cardiovascular Magnetic Resonance

  2009cited by this paper
• Cardiac sarcoidosis.

  2009cited by this paper
• The Current and Emerging Role of Cardiovascular Magnetic Resonance Imaging in Hypertrophic Cardiomyopathy

  2009cited by this paper
• Accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis

  2009cited by this paper
• Coronary Sarcoidosis Presenting as Acute Coronary Syndrome

  2009cited by this paper
• Sarcoidosis

  2009cited by this paper
• Cardiovascular magnetic resonance in myocarditis: A JACC White Paper.

  2009cited by this paper
• Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major

  2009cited by this paper
• Diagnostic, prognostic, and therapeutic implications of genetic testing for hypertrophic cardiomyopathy.

  2009cited by this paper
• Utility of cardiovascular magnetic resonance in the diagnosis of Anderson-Fabry disease.

  2009cited by this paper
• Application of cardiac magnetic resonance imaging in cardiomyopathy

  2008cited by this paper
• Delayed enhancement cardiac magnetic resonance imaging reveals typical patterns of myocardial injury in patients with various forms of non-ischemic heart disease

  2008cited by this paper
• Myocardial T  2* measurements in iron‐overloaded thalassemia: An in vivo study to investigate optimal methods of quantification

  2008cited by this paper
• Myocardial fibrosis of left ventricle: Magnetic resonance imaging in noncompaction

  2008cited by this paper
• Quantification of left ventricular noncompaction and trabecular delayed hyperenhancement with cardiac MRI: correlation with clinical severity.

  2007cited by this paper
• Clinical features and usefulness of cardiac magnetic resonance imaging in assessing myocardial viability and prognosis in Takotsubo cardiomyopathy (transient left ventricular apical ballooning syndrome).

  2007cited by this paper
• Myocardial T1 mapping: Application to patients with acute and chronic myocardial infarction

  2007cited by this paper
• Usefulness of delayed enhancement magnetic resonance imaging to differentiate dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy.

  2007cited by this paper
• Late gadolinium enhancement-cardiovascular magnetic resonance as a predictor of response to cardiac resynchronization therapy in patients with ischaemic cardiomyopathy.

  2007cited by this paper
• Cardiovascular magnetic resonance in arrhythmogenic right ventricular cardiomyopathy revisited: comparison with task force criteria and genotype.

  2006cited by this paper
• Multimodality imaging to diagnose takotsubo cardiomyopathy

  2006cited by this paper
• Magnetic resonance imaging in the evaluation of non-ischemic cardiomyopathies: Current applications and future perspectives

  2006cited by this paper
• Characterization of the Peri-Infarct Zone by Contrast-Enhanced Cardiac Magnetic Resonance Imaging Is a Powerful Predictor of Post–Myocardial Infarction Mortality

  2006cited by this paper
• Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interd

  2006cited by this paper
• Prevalence, Clinical Profile, and Significance of Left Ventricular Remodeling in the End-Stage Phase of Hypertrophic Cardiomyopathy

  2006cited by this paper
• Cardiac sarcoidosis

  2006cited by this paper
• Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches.

  2005cited by this paper
• Cardiac sarcoidosis: spectrum of MRI features.

  2005cited by this paper
• Myocardial viability assessment in patients with highly impaired left ventricular function: comparison of delayed enhancement, dobutamine stress MRI, end-diastolic wall thickness, and TI201-SPECT with functional recovery after revascularization

  2005cited by this paper
• Cardiovascular magnetic resonance in cardiac amyloidosis.

  2005cited by this paper
• Sudden Death in Young Adults: A 25-Year Review of Autopsies in Military Recruits

  2004cited by this paper
• F-18-FDG uptake is a reliable predictory of functional recovery of akinetic but viable infarct regions as defined by magnetic resonance imaging before and after revascularization.

  2004cited by this paper
• The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy.

  2004cited by this paper
• Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance

  2004cited by this paper
• Magnetic Resonance Low-Dose Dobutamine Test Is Superior to Scar Quantification for the Prediction of Functional Recovery

  2004cited by this paper
• A single breath‐hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload

  2003cited by this paper
• Fabry disease

  2003cited by this paper
• Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance.

  2003cited by this paper
• T1 mapping in patients with acute myocardial infarction.

  2003cited by this paper
• Noninvasive and invasive evaluation of noncompaction cardiomyopathy.

  2002cited by this paper
• Assessment of myocardial viability by cardiovascular magnetic resonance imaging.

  2002cited by this paper
• Assessment of myocardial viability by cardiovascular magnetic resonance imaging.

  2002cited by this paper
• Accuracy of Contrast-Enhanced Magnetic Resonance Imaging in Predicting Improvement of Regional Myocardial Function in Patients After Acute Myocardial Infarction

  2002cited by this paper
• Visualization of Discrete Microinfarction After Percutaneous Coronary Intervention Associated With Mild Creatine Kinase-MB Elevation

  2001cited by this paper
• MR findings of myocardial sarcoidosis.

  2000cited by this paper
• The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction.

  2000cited by this paper
• Detection of myocardial viability by low-dose dobutamine Cine MR imaging.

  1999cited by this paper
• Relationship of elevated 23Na magnetic resonance image intensity to infarct size after acute reperfused myocardial infarction.

  1999cited by this paper
• T2‐weighted breath‐hold MRI of the liver at 1.0 T: Comparison of turbo spin‐echo and HASTE sequences with and without fat suppression

  1998cited by this paper
• Medical progress : Sarcoidosis

  1997cited by this paper
• Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization.

  1997cited by this paper
• Comparison of low-dose dobutamine-gradient-echo magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability.

  1995cited by this paper
• Echocardiographic evaluation of patients with systemic sarcoidosis.

  1985cited by this paper
• Constrictive pericarditis associated with sarcoidosis.

  1984cited by this paper
• Cardiac Sarcoid: A Clinicopathologic Study of 84 Unselected Patients with Systemic Sarcoidosis

  1978cited by this paper
• Journal of Cardiovascular Magnetic Resonance Open Access Cardiovascular Magnetic Resonance and Prognosis in Cardiac Amyloidosis

  year unknowncited by this paper

• Our experience with cardiac MRI in a tertiary health care center in Nepal

  2024cites this paper
• Assessment of Cardiomyopathies and Cardiac Transplantation

  2019cites this paper
• CMR in Phenotyping the Arrhythmic Substrate

  2017cites this paper
• Ischemic left ventricle systolic dysfunction: An evidence-based approach in diagnostic tools and therapeutics.

  2017cites this paper
• Letter to Editor: Functional study is not the only criterion to predict the pathogenicity of a novel mutation for cardiomyopathy.

  2017cites this paper
• Cardiac magnetic resonance and galectin-3 level as predictors of prognostic outcomes for non-ischemic cardiomyopathy patients

  2016cites this paper
• The role of myocardial wall thickness in atrial arrhythmogenesis.

  2016cites this paper